Fernand Labrie
Publications
Page 13 of 25, showing 50 records out of 1234 total, starting on record 601, ending on 650
| Publication | Category | Year |
|---|---|---|
| 634. Dupont, E., Luu-The, V., Labrie, F., Pelletier, G. (1990) Light microscopic immunocytochemical localization of 3?-hydroxy steroid dehydrogenase/?5-?4 isomerase (3?-HSD) in the gonads and adrenal glands of the guinea pig. Endocrinology, 126: 2906-2909. | All publications | 1990 |
| 633. Dupont, E., Luu-The, V., Labrie, F., Pelletier, G. (1990) Ontogeny of 3?-hydroxysteroid dehydrogenase/ ?5-?4 isomerase (3?-HSD) in human adrenal gland performed by immunocytochemistry. Mol. Cell. Endocrinol., 74: R7-R10. | All publications | 1990 |
| 632. Dupont, E., Zhao, H.F., Rhéaume, E., Simard, J., Luu-The, V., Labrie, F., Pelletier, G. (1990) Localization of 3?-hydroxysteroid dehydrogenase/?5-?4 isomerase in the rat gonads and adrenal glands by immunocytochemistry and in situ hybridization. Endocrinology, 127: 1394-1403. | All publications | 1990 |
| 631. Lachance, Y., Luu-The, V., Labrie, C., Simard, J., Dumont, M., de Launoit, Y., Guérin, S., Leblanc, G., Labrie, F. (1990) Characterization of human 3?-hydroxysteroid dehydrogenase/?5?4-isomerase gene and its expression in mammalian cells. J. Biol. Chem, 265: 20469-20475. | All publications | 1990 |
| 630. Luu-The, V., Labrie, C., Simard, J., Lachance, Y., Zhao, H.F., Couët, J., Leblanc, G., Labrie, F. (1990) Structure of two in tandem human 17?-hydroxysteroid dehydrogenase genes. Mol. Endocrinol., 4: 268-275. | All publications | 1990 |
| 629. Luu-The, V., Takahashi, M., Labrie, F. (1990) Purification of microsomal and mitochondrial 3?-hydroxysteroid dehydrogenase/?4?5 isomerase from human placenta, in: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F., eds: Steroid Formation, Degradation and Action in Peripheral Tissues, Normal and Neoplastic Tissues, Ann. New York Acad. Sci., pp 386-388. | All publications | 1990 |
| 628. Martel, C., Labrie, C., Couet, J., Dupont, E., Trudel, C., Luu-The, V., Takahashi, M., Pelletier, G., Labrie, F. (1990) Effects of human chorionic gonadotropin (hCG) and prolactin (PRL) on 3?-hydroxy-5-ene-steroid dehydrogenase/?5-?4 isomerase (3?-HSD) expression and activity in the rat ovary. Mol. Cell. Endocrinol., 72: R7-R13. | All publications | 1990 |
| 627. Martel, C., Labrie, C., Dupont, E., Couët, J., Trudel, C., Rheaume, E., Simard, J., Luu-The, V., Pelletier, G., Labrie, F. (1990) Regulation of 3?-hydroxysteroid dehydrogenase/?5-?4 isomerase expression and activity in the hypophysectomized rat ovary: interactions between the stimulatory effect of human chorionic gonadotropin and the luteolytic effect of prolactin. Endocrinology, 127: 2726-2737. | All publications | 1990 |
| 626. Simard, J., Labrie, C., Mérand, Y., Dufour, J.-M., Lévesque, C., Labrie, F. (1990) Pure antagonistic effect of a new steroidal antiestrogen in rat anterior pituitary cells in culture and in mouse uterus, in: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F., eds: Steroid Formation, Degradation and Action in Peripheral Tissues, Normal and Neoplastic Tissues, Ann. New York Acad. Sci., pp 425-427. | All publications | 1990 |
| 625. Takahashi, M., Luu-The, V., Labrie, F. (1990) Inhibitory effect of synthetic progestins, 4-MA and cyanoketone on human placental 3?-hydroxysteroid dehydrogenase/?5-?4 isomerase activity. J. Steroid Biochem. Mol. Biol., 37: 231-236. | All publications | 1990 |
| 624. Takahashi, M., Luu-The, V., Labrie, F. (1990) Purified microsomal and mitochondrial 3?-hydroxysteroid dehydrogenase/?4-?5 isomerase from human placenta. Characterization of substrate and inhibitor specificity, in: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F., eds: Steroid Formation, Degradation and Action in Peripheral Tissues, Normal and Neoplastic Tissues, Ann. New York Acad. Sci., pp 383-385. | All publications | 1990 |
| 623. Tong, Y., Zhao, H., Labrie, F., Pelletier, G. (1990) Effects of estrogens on the ultrastructural characteristics of female rat prolactin cells as evaluated by in situ hybridization in combination with immunogold staining technique. Neuroendocrinology, 52: 309-315. | All publications | 1990 |
| 622. Tong, Y., Zhao, H., Labrie, F., Pelletier, G. (1990) Regulation of proopiomelanocortin messenger ribonucleic acid content by sex steroids in the arcuate nucleus of the female rat brain. Neurosci. Lett., 112: 104-108. | All publications | 1990 |
| 621. Zhao, H.F., Rhéaume, E., Trudel, C., Couet, J., Labrie, F., Simard, J. (1990) Structure and sexual dimorphic expression of a liver-specific rat 3?-hydroxysteroid dehydrogenase/isomerase. Endocrinology, 127: 3237-3239. | All publications | 1990 |
| 620. Zorilla, R., Simard, J., Rhéaume, E., Labrie, F., Pelletier, G. (1990) Multihormonal control of pre-prosomatostatin mRNA levels in the periventricular nucleus of the male and female rat hypothalamus. Neuroendocrinology, 52: 527-536. | All publications | 1990 |
| 619. Tice, T., Labrie, F., McRae-Degueurce, A., Dillon, L., Mason, D.W., Gilley, R.M. (1990) Recent developments with poly(lactide-co-glycolide) microspheres. Polym. Prepr. (Am. Chem. Soc.), 31: 185-186. | All publications | 1990 |
| 618. Poulin, R., Baker, D., Poirier, D., Labrie, F. (1990) Multiple actions of synthetics "progestins" on the growth of ZR-75-1 human breast cancer cells: An in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids. Breast Cancer Res Treat, 17: 197-210. | All publications | 1990 |
| 617. Poirier, D., Labrie, C., Mérand, Y., Labrie, F. (1990) Derivatives of ethynylestradiol with oxygenated 17?-alkyl side chain: synthesis and biological activity. J. Steroid Biochem., 36: 133-142. | All publications | 1990 |
| 616. Moorjani, S., Dupont, A., de Lignières, B., Labrie, F., Lupien, P.J. (1990) The effects of oral and nonoral estrogen replacement on plasma low density lipoprotein, in Christiansen, C. et Overgard, K., eds: Osteoporosis 1990, pp 1942-1946. | All publications | 1990 |
| 615. Luu-The, V., Labrie, C., Zhao, H.F., Couet, J., Lachance, Y., Simard, J., Côté, J., Leblanc, G., Lagacé, L., Bérubé, D., Gagné, R., Labrie, F. (1990) Purification, cloning, complementary DNA structure and predicted amino acid sequence of human estradiol 17?-dehydrogenase, in: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F., eds: Steroid Formation, Degradation and Action in Peripheral Tissues, Normal and Neoplastic Tissues, Ann. New York Acad. Sci., pp 40-52. | All publications | 1990 |
| 614. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Lacourcière, Y., Monfette, G., Emond, J. (1990) Maximal androgen blockade in prostate cancer: To-day's therapy of choice and 5-year clinical experience, in: Vickery, B.H. et Lunenfeld, B., eds: GnRH analogues in cancer and human reproduction, pp 79-102. | All publications | 1990 |
| 613. Dupont, A., Dupont, P., Bélanger, A., Mailloux, J., Cusan, L., Labrie, F. (1990) Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6,des-Gly-NH210]LHRH ethylamide. Fertil. Steril., 54: 227-232. | All publications | 1990 |
| 612. Chedrese, P.J., Zhang, D., Luu-The, V., Labrie, F., Juorio, A.V., Murphy, B.D. (1990) Regulation of mRNA expression of 3 ?-hydroxy-5-ene steroid dehydrogenase in porcine granulosa cells in culture: a role for the protein kinase-C pathway. Mol. Endocrinol., 4: 1532-1538. | All publications | 1990 |
| 611. Bélanger, B., Bélanger, A., Labrie, F., Dupont, A., Cusan, L., Monfette, G. (1989) Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J. Steroid Biochem., 32: 695-698. | All publications | 1989 |
| 610. Dupont, A., Labrie, F., Manhès, G., Bergeron, N., Cusan, L., Pinault, S., Bélanger, A., Boucher, M., Lacourcière, Y., Emond, J. (1989) Combination therapy with Flutamide and the LHRH agonist [D-Trp6, des-Gly-NH210]LHRH ethylamide in stage C prostatic carcinoma, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 89-102. | All publications | 1989 |
| 609. Emond, J., Dupont, A., Cusan, L., Bergeron, N., Manhès, G., Labrie, F. (1989) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) as an alternative to transurethral resection of the prostate for urinary retention in prostate cancer, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, pp 103-108. | All publications | 1989 |
| 608. Labrie, C., Simard, J., Marchetti, B., Pelletier, G., Zhao, H.F., Bélanger, A., Labrie, F. (1989) Conversion of precursor adrenal steroids into potent androgens in peripheral tissue, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 1-22. | All publications | 1989 |
| 607. Labrie, C., Simard, J., Zhao, H., Bélanger, A., Pelletier, G., Labrie, F. (1989) Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology, 124: 2745-2754. | All publications | 1989 |
| 606. Labrie, F. (1989) Criteria of response of stage D2 prostate cancer [Letter to the Editor: Reply to Newling et al. re 24: 1869-78, 1988]. Eur. J. Cancer Clin. Oncol., 25: 1259-1260. | All publications | 1989 |
| 605. Labrie, F. (1989) Medical treatment of prostate cancer. Drug Therapy, 19: 22-37. | All publications | 1989 |
| 604. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Brochu, M., Turina, E., Pinault, S., Lacourcière, Y., Emond, J. (1989) Anti-hormone treatment in stage D2 prostate cancer patients relapsing under treatment with Flutamide and castration: addition of aminoglutethimide and low dose hydrocortisone to combination therapy. Br. J. Urol., 63: 634-638. | All publications | 1989 |
| 603. Labrie, F., Dupont, A., Cusan, L., Giguère, M., Bergeron, N., Lacourcière, Y., Bélanger, A., Monfette, G., Emond, J. (1989) Terapia combinada con flutamida y (D-TRP6)LH-RH etilamida en el cancer de prostata en estadio D2 sin tratamiento previo, in: Pontes, J.E., Mallo, N. et Zungri, E., eds: Cancer de Prostata, ulso Ediciones, Barcelona, Actualizaciones Urologicas, pp 73-86. | All publications | 1989 |
| 602. Labrie, F., Dupont, A., Cusan, L., Labrie, C., Lacoste, D., Luu-The, V., Manhès, G., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) Today's endocrine therapy of prostate cancer, in Fourth International Symposium on Transrectal Ultrasound in the Diagnosis and Management of Prostate Cancer, New York, Alan R. Liss Inc., pp 223-235. | All publications | 1989 |
| 601. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Bergeron, N., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) Combination therapy with castration and flutamide: to-day's treatment of choice for prostate cancer. J. Steroid Biochem., 33: 817-821. | All publications | 1989 |
| 600. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Bergeron, N., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) Combination therapy with Flutamide and castration: its benefits at various stages of prostate cancer, in: Murphy, G.P. et Khoury, S., eds: Progress in Clinical and Biological Research, New York, Alan R. Liss Inc., pp 161-167. | All publications | 1989 |
| 599. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Bergeron, N., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) LHRH agonists and prostate cancer: an example of rapid development of a new class of drugs, in: Chiou, S.H., Wang, K.T. et Wu, S.H., eds: International Symposium on Biologically Active Proteins and Peptides, July 13-15, 1988, Taipei, Taiwan, pp 129-136. | All publications | 1989 |
| 598. Lacoste, D., Caron, S., Bélanger, A., Labrie, F. (1989) Effect of 3-week treatment with [D-Trp6, des-Gly-NH210]LHRH ethylamide, aminoglutethimide, ketoconazole or Flutamide alone or in combination on testicular, serum, adrenal and prostatic steroid levels in the dog. J. Steroid Biochem., 33: 233-242. | All publications | 1989 |
| 597. Lacoste, D., Dubé, D., Bélanger, A., Labrie, F. (1989) Effect of 2-week combination therapy with the LHRH agonist [D-Trp6,des-Gly-NH2]LHRH ethylamide and the antiandrogen Flutamide on prostate structure and steroid levels in the dog. Mol. Cell. Endocrinol., 67: 131-138. | All publications | 1989 |
| 596. Lacoste, D., Dubé, D., Trudel, C., Bélanger, A., Labrie, F. (1989) Normal gonadal functions and fertility after 23 months of treatment of prepubertal male and female dogs with the GnRH agonist [D-Trp6,des-Gly-NH210]LHRH ethylamide. J. Androl., 10: 456-465. | All publications | 1989 |
| 595. Lacoste, D., Labrie, F., Dubé, D., Bélanger, A., Tice, T., Gilley, R.M., Pledger, K.L. (1989) Reversible inhibition of testicular androgen secretion by 3-, 5- and 6-month controlled-release microsphere formulations of the LHRH agonist [D-Trp6,des-Gly-NH210]LHRH ethylamide in the dog. J. Steroid Biochem., 33: 1007-1011. | All publications | 1989 |
| 594. Monfette, G., Dupont, A., Labrie, F. (1989) Temporary combination therapy with Flutamide and Tryptex as adjuvant to radical prostatectomy for the treatment of early stage prostate cancer, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 41-42. | All publications | 1989 |
| 593. Monfette, G., Dupont, A., Pinault, S., Gagnon, J., Boivin, J.C., Têtu, B., Labrie, F. (1989) Advantages of downstaging local prostate cancer by 3-month combination therapy prior to radical prostatectomy, in Fourth International Symposium on Transrectal Ultrasound in the Diagnosis and Management of Prostate Cancer, New York, Alan R. Liss Inc., pp 255-261. | All publications | 1989 |
| 592. Pinault, S., Gagnon, J., Monfette, G., Têtu, B., Dupont, A., Labrie, F. (1989) Transrectal ultrasound evaluation of local disease in prostate cancer patients treated with the combination therapy, in: Labrie, F., Lee, F. et Dupont, A., eds: Early State Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 53-62. | All publications | 1989 |
| 591. Têtu, B., Labrie, F., Dupont, A., Monfette, G. (1989) Histopathologic effect of combination therapy on normal prostate and prostatic adenocarcinoma, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, Exerpta Medica ICS 841, pp 63-76. | All publications | 1989 |
| 590. Dauvois, S., Labrie, F. (1989) Androstenedione and androst-5-ene-3?, 17?-diol stimulate DMBA-induced rat mammary tumors-role of aromatase. Breast Cancer Res. Treat., 13: 61-69. | All publications | 1989 |
| 589. Dauvois, S., Li, S., Martel, C., Labrie, F. (1989) Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 14: 299-306. | All publications | 1989 |
| 588. Dauvois, S., Spinola, P.G., Labrie, F. (1989) Additive inhibitory effects of bromocriptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat. Eur. J. Cancer Clin. Oncol., 25: 891-897. | All publications | 1989 |
| 587. Dumont, M., Dauvois, S., Simard, J., Garcia, T., Schachter, B., Labrie, F. (1989) Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. J. Steroid Biochem., 34: 397-402. | All publications | 1989 |
| 586. Marchetti, B., Spinola, P., Plante, M., Poyet, P., Folléa, N., Pelletier, G., Labrie, F. (1989) ?-adrenergic receptors in dimethylbenz(?)anthracene(DMBA)-induced rat mammary tumors: Correlation with progesterone receptor levels and tumor growth. Breast Cancer Res. Treat., 13: 251-263. | All publications | 1989 |
| 585. Poulin, R., Baker, D., Poirier, D., Labrie, F. (1989) Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 13: 161-172. | All publications | 1989 |